文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

内科ICU急性肾损伤可逆性预测:尿TIMP-2×IGFBP-7与肾阻力指数的表现

Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在内科ICU急性肾损伤患者中,肾阻力指数预测持续性急性肾损伤的AUC为0.93,而尿TIMP-2×IGFBP-7无法区分一过性与持续性急性肾损伤。

这项前瞻性观察研究在20张床位的大学医院内科ICU连续纳入100例急性肾损伤患者,其中50例为持续性急性肾损伤。入ICU后12小时内测量肾阻力指数,并在H0、H6、H12、H24测量尿TIMP-2×IGFBP-7,第3天评估肾功能恢复情况。肾阻力指数在持续性急性肾损伤组更高,预测持续性急性肾损伤的AUC为0.93(95%CI 0.89-0.98);以≥0.685为阈值,敏感度78%(95%CI 64-88%),特异度90%(95%CI 78-97%)。尿TIMP-2×IGFBP-7各时间点两组间无显著差异,AUC分别为0.57、0.58、0.61、0.57,表现差。

要点

  • 肾阻力指数预测持续性急性肾损伤的AUC为0.93(95%CI 0.89-0.98),表现良好。
  • 肾阻力指数≥0.685预测持续性急性肾损伤的敏感度78%(95%CI 64-88%),特异度90%(95%CI 78-97%)。
  • 持续性急性肾损伤组肾阻力指数高于非持续性组。
  • 尿TIMP-2×IGFBP-7在H0、H6、H12、H24各时间点两组间无显著差异,AUC 0.57-0.61,无法区分一过性与持续性急性肾损伤。
  • 肾阻力指数在入ICU后12小时内测量,尿TIMP-2×IGFBP-7在H0、H6、H12、H24测量,第3天评估肾功能恢复。

适用人群与场景

  • 连续纳入大学医院20张床位的内科ICU中发生急性肾损伤的成人患者。
  • 研究为前瞻性观察性研究,无干预。

诊断标准与关键阈值

  • 肾阻力指数≥0.685用于预测持续性急性肾损伤,敏感度78%(95%CI 64-88%),特异度90%(95%CI 78-97%)。

研究设计与关键结果

  • 前瞻性观察性研究,纳入100例急性肾损伤患者,其中50例为持续性急性肾损伤。
  • 肾阻力指数在入ICU后12小时内测量;持续性急性肾损伤组肾阻力指数高于非持续性组。
  • 尿TIMP-2×IGFBP-7在H0、H6、H12、H24各时间点两组间无显著差异。
  • 尿TIMP-2×IGFBP-7预测持续性急性肾损伤的AUC分别为H0 0.57(95%CI 0.45-0.68)、H6 0.58(95%CI 0.47-0.69)、H12 0.61(95%CI 0.50-0.72)、H24 0.57(95%CI 0.46-0.68)。
  • 肾阻力指数预测持续性急性肾损伤的AUC为0.93(95%CI 0.89-0.98)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为肾阻力指数在预测危重患者急性肾损伤可逆性方面表现良好。
  • 作者认为尿TIMP-2×IGFBP-7无法区分一过性与持续性急性肾损伤。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Urinary biomarkers and renal Doppler sonography remain considered as promising tools to distinguish transient from persistent acute kidney injury. The performance of the urinary biomarker, tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 and of renal resistive index to predict persistent acute kidney injury showed contradictory results. Our aim was to evaluate the performance of tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 and renal resistive index in predicting reversibility of acute kidney injury in critically ill patients.

DESIGN: Prospective observational study.

SETTING: Twenty-bed medical ICU in an university hospital.

PATIENTS: Consecutive patients with acute kidney injury.

MEASUREMENTS AND MAIN RESULTS: Renal resistive index was measured within 12 hours after admission, and urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 was measured at H0, H6, H12, and H24. Renal dysfunction reversibility was evaluated at day 3. Receiver operating characteristic curves were plotted to evaluate diagnostic performance of renal resistive index and tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 to predict a persistent acute kidney injury. Overall, 100 patients were included in whom 50 with persistent acute kidney injury. Renal resistive index was higher in persistent acute kidney injury group. Urinary tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was not significantly different at each time between both groups. The performance of tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was poor with respectively an area under the receiver operating characteristic curves of 0.57 (95% CI, 0.45-0.68), 0.58 (95% CI, 0.47-0.69), 0.61 (95% CI, 0.50-0.72), and 0.57 (95% CI, 0.46-0.68) at H0, H6, H12, and H24. The area under the receiver operating characteristic curve for renal resistive index was 0.93 (95% CI, 0.89-0.98). A renal resistive index greater than or equal to 0.685 predicting persistent acute kidney injury with 78% (95% CI, 64-88%) sensitivity and 90% (95% CI, 78-97%) specificity.

CONCLUSIONS: Renal resistive index had a good performance for predicting the reversibility of acute kidney injury in critically ill patients. Urinary tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was unable to differentiate transient from persistent acute kidney injury.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Garnier F, Daubin D, Larcher R, et al. Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index. Crit Care Med. 2020. PMID: 32205617. doi:10.1097/CCM.0000000000004218

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。